GL1X · GenesisL1 explorer

Research workbench

Vaccinia virus F1L bound to bak BH3

Analyse Vaccinia virus F1L bound to bak BH3 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4D2L
Type
protein
Length
161 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Protein F1L; BCL-2 homologous ANTAGONIST/KILLER
UniProt
O57173, Q16611
Pockets
3 · best druggability 0.49

Structure

x-ray diffraction · 2 distinct chains · 78% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProtein F1Lprotein13879% helix, 0% strandO57173
BBCL-2 homologous ANTAGONIST/KILLERprotein2370% helix, 0% strandQ16611

Pockets

3 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12280.490.7423empty
21430.460.7618empty
31230.370.7319empty

Interfaces

1 interface between chains.

  • A–B · 900 Ų buried · 8 hydrogen bonds · protein-protein

Compared structures

  • 4D2L · Vaccinia Virus F1L bound to Bak BH3 · the same entry in another collection · chain A against A, TM-score 1.00
  • Q16611 · AlphaFold monomer V2.0 prediction for BCL-2 homologous ANTAGONIST/KILLER (Q16611) · a predicted model of the same protein · chain B against A, TM-score 0.70

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.